Derryl Roderick
Friday, 16 September 2016
EpiPen Maker Lobbies to Shift High Costs to Others
Inclusion on a federal list would mean Mylan could keep its list price high - or even raise it - without patients' complaining. But consumers would feel it indirectly.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment